Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term improvement of slow-channel congenital myasthenic syndrome with fluoxetine.

Neuromuscular disorders : NMD - 1 May 2006

Colomer J, Müller J S, Vernet A, Nascimento A, Pons M, Gonzalez V, Abicht A, Lochmüller H

Abstract excerpt

We report on a 15-year-old patient who was diagnosed with congenital myasthenic syndrome (CMS) at the age of 7 months. At initial diagnosis, the CMS was not further characterized. The patient was treated for several years with the anticholinesterase drug (Mestinon), without clinical benefit. The patient deteriorated progressively and became dependent on home nocturnal ventilatory support, being unable to take...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholinesterase Inhibitors
Share to Fluoxetine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myasthenic Syndromes, Congenital

Share to Neuromuscular Junction

Share to Receptors, Cholinergic

Share to Recovery of Function

Share to Selective Serotonin Reuptake Inhibitors

Source

Identifiers

PMID: 16621558
DOI: 10.1016/j.nmd.2006.02.009

Genes

CHRNE

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term improvement of slow-channel congenital myasthenic syndrome with fluoxetine.PMID 16621558Read ↗

Clinical and neurophysiological response to ephedrine in a patient affected with slow-channel congenital myasthenic syndrome.Semantic proximity Read ↗

Congenital myasthenic syndromes.Semantic proximity Read ↗

Treatment of slow-channel congenital myasthenic syndrome in a Thai family with fluoxetine.Semantic proximity Read ↗

Rapsyn congenital myasthenic syndrome worsened by fluoxetine.Semantic proximity Read ↗

Quinine sulfate as a therapeutic option in a patient with slow channel congenital myasthenic syndrome.Semantic proximity Read ↗

Therapeutic strategies for congenital myasthenic syndromes.Semantic proximity Read ↗

Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up.Semantic proximity Read ↗

[Advances in the diagnosis and treatment of congenital myasthenic syndrome].Semantic proximity Read ↗

[Congenital diseases of neuromuscular transmission: congenital myasthenia syndromes].Semantic proximity Read ↗

A rare mutation in the COLQ gene causing congenital myasthenic syndrome with remarkable improvement to fluoxetine: A case report.Semantic proximity Read ↗

Clinical and neurophysiological response to pharmacological treatment of DOK7 congenital myasthenia in an older patient.Semantic proximity Read ↗

Congenital myasthenic syndrome with episodic apnoea: clinical, neurophysiological and genetic features in the long-term follow-up of 19 patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.